Long-term Follow-up of Patients Treated With Genetically Modified Autologous T Cells
This research is looking at patients in the UK who have received a special type of cancer treatment called AUTO CAR T cell therapy. This treatment is used for certain blood cancers like multiple myeloma and lymphoma. The main goal is to follow these patients for a very long time, up to 15 years, after they first had the therapy. Doctors want to understand any long-term side effects, make sure the treatment is still working, and check for any new health problems that might appear much later. By collecting this information, they can learn more about how safe and effective this important treatment is over many years, helping future patients who might need it.
At a glance
What is this study about?
This study is designed to keep a close eye on people who have been treated with a new type of therapy called AUTO CAR T cell therapy. This treatment is a special way to fight some blood cancers like multiple myeloma and different types of lymphoma in both children and adults. Think of it like training your own body's immune cells to become super-fighters against cancer.
The main purpose of this study is to quietly observe and learn from this group of patients for a long time – up to 15 years after they first received their treatment. Doctors want to understand everything about how the treatment affects them.
They'll be looking out for any rare or late side effects that might not show up right away. They also want to see if the treatment continues to work well over time and make sure no new health issues arise because of it. All of this information is really important to help doctors understand the full picture of this new therapy, making it safer and better for everyone who might need it in the future.
Key takeaways
- This study tracks patients who had AUTO CAR T cell therapy for cancer.
- It aims to understand the long-term effects over 15 years.
- Participation involves ongoing monitoring, like check-ups and tests.
- It helps gather vital information for future cancer treatments.
- You must have already received AUTO CAR T cell therapy to join.
- You can stop participating at any time without impacting your care.
Who may be eligible?
To be part of this follow-up study, you must have already had a specific cancer treatment called AUTO CAR T cell therapy as part of a previous medical study. The doctors providing your care will know if this applies to you.
Before you join, you need to understand what the study involves and agree to take part by signing a consent form. This ensures you're happy with the process and have had all your questions answered.
Finally, you should be able to follow the study's instructions. This means being able to attend any necessary appointments or provide information as requested by the study team. There are no reasons that would specifically prevent someone from joining this follow-up if they meet the above points.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Have I previously received AUTO CAR T cell therapy for my cancer?
- Am I willing to provide my informed consent to join the study?
- Can I attend follow-up appointments and provide information as needed?
- Am I over 1 year old (there is no upper age limit)?
What does participation involve?
If you join this study, it means you'll be part of a long-term follow-up. This involves regular check-ups with your medical team. These appointments are designed to monitor your health and how you're doing after your AUTO CAR T cell therapy.
During these visits, you might have blood tests or other assessments, but you won't be given any new medication as part of this specific study. The study team will be looking for any signs of late side effects or if the treatment is still working. The total duration of your participation could be up to 15 years from when you first received your AUTO CAR T cell therapy.
Potential risks and benefits
Locations (8)
- University of MiamiVerified postcodeMiami, United States
- Washington University in St. LouisVerified postcodeSt Louis, United States
- St David's South Austin Medical CenterVerified postcodeAustin, United States
- Queen Elizabeth University HospitalVerified postcodeGlasgow, United Kingdom
- University College London Hospitals NHS Foundation TrustVerified postcodeLondon, United Kingdom
- Manchester Royal Infirmary HospitalVerified postcodeManchester, United Kingdom
- Royal Manchester Children's HospitalVerified postcodeManchester, United Kingdom
- Freeman Hospital, The Newcastle upon Tyne Hospitals NHS Foundation TrustVerified postcodeNewcastle upon Tyne, United Kingdom
Common questions
What is AUTO CAR T cell therapy?
It's a special cancer treatment where your own immune cells are collected, trained in a lab to fight your cancer, and then given back to you.
Why is this study important?
It helps doctors learn about the long-term effects of this new treatment – both good and bad – so they can make it better and safer for everyone.
How long will I be followed in this study?
You could be followed for up to 15 years after you first received your AUTO CAR T cell therapy.
Will I receive any new treatment in this study?
No, this study is only for monitoring. You will not receive any new or experimental medications as part of this follow-up.
Can I stop participating in the study if I change my mind?
Yes, you can choose to leave the study at any time, and it won't affect your regular medical care.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Interested in taking part?
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.